Z-0529-2019 Class III Terminated
FDA device recall Z-0529-2019 was initiated by Helena Laboratories, Inc. on Nov 7, 2016 and is designated Class III. Reason for recall: Due to a customer experiencing complaints on bone fraction of assay not being in range. The complaint: ~12% lower enzyme activity was noted. The recall status is terminated (terminated Jan 15, 2021). Affected quantity: 43 kits (6 kits Domestic/37 Internationally).
Recall details
- Product Type
- Devices
- Report Date
- Dec 12, 2018
- Initiation Date
- Nov 7, 2016
- Termination Date
- Jan 15, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 43 kits (6 kits Domestic/37 Internationally)
Product description
Reason for recall
Distribution pattern
Worldwide Distribution: US (nationwide) to states of: GA, IN, and MI, and countries of: Australia, Brazil, Canada, Japan and Hong Kong.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0529-2019
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Helena Laboratories, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.